lyngbyatoxin a has been researched along with pendolmycin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Billingsley, KL; Leister, J; Malepeai-Tofaeono, T; Mendoza, M; Ondrus, AE; To, K; Tran, U; Zhang, GC | 1 |
Fujiki, H; Furuya-Suguri, H; Muratake, H; Nakayasu, M; Natsume, M; Nishiwaki, S; Okabe, K; Okabe, S; Suganuma, M; Yoshizawa, S | 1 |
Eiting, J; Philmus, B; Proteau, PJ; Singh, AJ; Videau, P; Wells, KN | 1 |
3 other study(ies) available for lyngbyatoxin a and pendolmycin
Article | Year |
---|---|
Indolactam Dipeptides as Nanomolar Gli Inhibitors.
Topics: | 2022 |
Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
Topics: Alkaloids; Animals; Carcinogens; Enzyme Activation; Female; Indoles; Lactams; Lyngbya Toxins; Mice; Mice, Inbred Strains; Protein Kinase C; Skin; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tritium | 1991 |
Expanding the Natural Products Heterologous Expression Repertoire in the Model Cyanobacterium
Topics: Alkaloids; Anabaena; Bacterial Proteins; Biological Products; Codon; Genes, Bacterial; Lyngbya Toxins; Metabolic Engineering; Multigene Family; Plasmids | 2020 |